unknown
Stage
1
Investors
About
Fluid Biomed develops a novel polymer-metal hybrid flow-diverting stent designed to treat brain aneurysms by promoting blood vessel healing and reducing the risk of rupture and stroke through clinical investigation.
Explore Fluid Biomed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.